Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of RNA01:23

Types of RNA

73.9K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.9K
Types of RNA01:20

Types of RNA

16.3K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
16.3K
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

1.1K
Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
1.1K
RNA Interference01:23

RNA Interference

28.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.7K
RNA Interference01:23

RNA Interference

7.9K
7.9K
Experimental RNAi02:15

Experimental RNAi

8.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A noncanonical RNA polymerase assembly pathway in Bacillus subtilis: α Dimer associates with either β or β' before forming the core enzyme.

The Journal of biological chemistry·2026
Same author

Unusual Hydrations of Amide I: An Insight into Protein Structure and Flexibility.

The journal of physical chemistry. B·2026
Same author

Development and efficacy testing of an artificial intelligence enabled treatment package (eDOSTHI) for tobacco cessation: study protocol for a randomized controlled trial.

BMC psychiatry·2026
Same author

Differential association of primary and alternative σ factors with RNA polymerase of Mycobacterium tuberculosis during transcription elongation.

Nucleic acids research·2026
Same author

<i>Bacillus subtilis</i> σ<sup>A</sup> and <i>Escherichia coli</i> σ<sup>70</sup> lacking σ region 1.1 are not released during transcription initiation and elongation.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Green Chemistry-Assisted Synthesis of Metal Nanoparticles and Fabrication of Microstructurally Engineered Conductive and Endurable M<sup>0</sup>@PEO Functional Films.

ACS omega·2025

Related Experiment Video

Updated: Apr 5, 2026

Novel RNA-Binding Proteins Isolation by the RaPID Methodology
11:19

Novel RNA-Binding Proteins Isolation by the RaPID Methodology

Published on: September 30, 2016

9.6K

RFA1 Inhibits Rifampicin-resistant RNA Polymerase by a Similar Mechanism as Rifampicin.

Sourajit Saha1, Aniruddha Tewary1, Sangita Ghosh Majumdar1

  • 1Department of Chemical Sciences, Bose Institute, Kolkata, India.

Journal of Molecular Biology
|April 3, 2026
PubMed
Summary

RFA1, a novel rifabutin analogue, effectively inhibits bacterial transcription initiation, including in rifampicin-resistant tuberculosis strains. This compound shows promise as a potential drug candidate for treating tuberculosis.

Keywords:
antibioticsbacteriarifampicintranscriptiontuberculosis

More Related Videos

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

878
Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.8K

Related Experiment Videos

Last Updated: Apr 5, 2026

Novel RNA-Binding Proteins Isolation by the RaPID Methodology
11:19

Novel RNA-Binding Proteins Isolation by the RaPID Methodology

Published on: September 30, 2016

9.6K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

878
Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.8K

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Rifampicin is a key anti-tuberculosis drug that inhibits RNA polymerase (RNAP).
  • Rifampicin resistance in TB strains arises from mutations in RNAP near the drug-binding site.
  • Novel agents are needed to combat rifampicin-resistant tuberculosis.

Purpose of the Study:

  • To investigate the mechanism of action of RFA1, a rifabutin analogue.
  • To determine RFA1's efficacy against rifampicin-resistant tuberculosis strains.
  • To evaluate RFA1 as a potential therapeutic agent for TB.

Main Methods:

  • In vitro transcription assays using wild-type and mutant RNAP.
  • Analysis of RFA1 binding and inhibition kinetics.
  • Assessment of RFA1 activity against rifampicin-resistant TB polymerase derivatives.

Main Results:

  • RFA1 inhibits transcription initiation by both wild-type and rifampicin-resistant RNAP.
  • RFA1, similar to rifampicin, does not inhibit transcription elongation beyond 3 nucleotides.
  • RFA1-resistant mutations in RNAP impair RFA1 binding and function, with minor effects on rifampicin.
  • Higher Mg2+ concentrations reduce RFA1's inhibitory effect.

Conclusions:

  • RFA1 is a potent inhibitor of bacterial transcription initiation.
  • RFA1 demonstrates activity against rifampicin-resistant TB strains.
  • RFA1 represents a promising drug candidate for treating both drug-susceptible and drug-resistant TB.